Methotrexate in the management of Crohn’s disease: A practice survey of gastroenterologists in France
Regardless of prescribing habits, most respondents had a favorable opinion of MTX and recognized its good long-term safety profile. French learned societies and medical associations should provide consensus guidelines on MTX use, supported by validated real-world safety and effectiveness data.
Authors
- Guillaume Bonnaud
- Agnès Courbeyrette
- Jennifer Becker (ORCID: https://orcid.org/0000-0002-6102-6402)
- Myriam Chebbah (ORCID: https://orcid.org/0009-0004-7507-4386)
- Patrick Fauré
Institutions
- Nordic Pharma (France) (FR)
- Health Affairs (US)
- Clinique Pasteur (FR)
- Clinique Ambroise Paré (FR)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.3748/wjg.v31.i33.108872
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82